Illumina (FRA:ILU) Beginning Cash Position : €850 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Illumina Beginning Cash Position?

Illumina's Beginning Cash Position for the quarter that ended in Dec. 2023 was €850 Mil.

Illumina's quarterly Beginning Cash Position increased from Jun. 2023 (€1,379 Mil) to Sep. 2023 (€1,455 Mil) but then declined from Sep. 2023 (€1,455 Mil) to Dec. 2023 (€850 Mil).

Illumina's annual Beginning Cash Position declined from Dec. 2021 (€1,602 Mil) to Dec. 2022 (€1,163 Mil) but then increased from Dec. 2022 (€1,163 Mil) to Dec. 2023 (€1,844 Mil).

Illumina Beginning Cash Position Historical Data

The historical data trend for Illumina's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Beginning Cash Position Chart

Illumina Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1,029.60

1,678.52

1,601.85

1,163.01

1,844.09

Illumina Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															944.00	1,878.27	1,378.96	1,455.16	850.06

Illumina Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Illumina Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Illumina's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Illumina (FRA:ILU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (FRA:ILU) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ILMN:USA ILMN:Mexico 1ILMN:Italy ILU:Germany ILMN:Austria

Address

5200 Illumina Way, San Diego, CA, USA, 92122

Website

https://www.illumina.com

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Illumina (FRA:ILU) Headlines

No Headlines